MetLife MET Whole and Term Life & Endowments — Benefit payments
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MetLife in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits.
The official record: MetLife’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MetLife's whole and term life & endowments — benefit payments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MetLife's whole and term life & endowments — benefit payments?
- MetLife (MET) reported whole and term life & endowments — benefit payments of -$256M in Q1 2026.
- How has MetLife's whole and term life & endowments — benefit payments changed year-over-year?
- MetLife's whole and term life & endowments — benefit payments decreased by 4.9% year-over-year, from -$244M to -$256M.
- What is the long-term trend for MetLife's whole and term life & endowments — benefit payments?
- Over 4 years (2021 to 2025), MetLife's whole and term life & endowments — benefit payments has grown at a -14.2% compound annual growth rate (CAGR), from -$1.79B to -$970M.
- What does whole and term life & endowments — benefit payments mean?
- This represents the actual cash outflows made to policyholders or beneficiaries for claims, maturities, or surrenders within the life and endowment segment. It is a direct measure of the liquidity requirements and the realization of insurance risk. Monitoring this helps evaluate the maturity profile and claim experience of the insurance portfolio.